ORILISSA

Abbvie Corporation🇨🇦 Health Canada

Approval Id: 705386fa912125be
Drug Approval Canada Name: ORILISSA
Product Name: ORILISSA
Status: Marketed
Status Date: 2019-05-24
Original Market Date: 2019-05-24
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: PRESCRIPTION
Ahfs: 68:18.04
Atc Original: H01CC03 ELAGOLIX
Aig Number: 0160710002
Company Name: Abbvie Corporation
Company Address: 8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1
Company Detail Path: /organization/abbvie-corporation

Agency

Health Canada

Country

🇨🇦

Approval Date

Apr 6, 2026

Approval ID

705386fa912125be

Type

Standard